Detalles de la búsqueda
1.
Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.
PLoS One
; 12(1): e0169566, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28081256
2.
FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mol Metab
; 6(6): 471-481, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28580278
3.
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.
Cell Metab
; 23(3): 427-40, 2016 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26959184
4.
Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family.
J Med Chem
; 59(3): 1165-75, 2016 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26734723
5.
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism.
ACS Chem Biol
; 11(9): 2529-40, 2016 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27391855
6.
Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5).
Sci Rep
; 5: 17391, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26620127
Resultados
1 -
6
de 6
1
Próxima >
>>